CL2009001796A1 - Compounds derived heteroaryl- (benzene / heteroaryl) fused glucagon antagonist activity; pharmaceutical composition; and their use for suppressing sugar production and for therapy or treatment of diabetes. - Google Patents

Compounds derived heteroaryl- (benzene / heteroaryl) fused glucagon antagonist activity; pharmaceutical composition; and their use for suppressing sugar production and for therapy or treatment of diabetes.

Info

Publication number
CL2009001796A1
CL2009001796A1 CL2009001796A CL2009001796A CL2009001796A1 CL 2009001796 A1 CL2009001796 A1 CL 2009001796A1 CL 2009001796 A CL2009001796 A CL 2009001796A CL 2009001796 A CL2009001796 A CL 2009001796A CL 2009001796 A1 CL2009001796 A1 CL 2009001796A1
Authority
CL
Chile
Prior art keywords
heteroaryl
diabetes
fused
benzene
therapy
Prior art date
Application number
CL2009001796A
Other languages
Spanish (es)
Inventor
Banno Yoshihiro
Hara Ryoma
Tokunoh Ryosuke
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2009025511 priority Critical
Priority to PCT/JP2009/054095 priority patent/WO2009110520A1/en
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of CL2009001796A1 publication Critical patent/CL2009001796A1/en

Links

Abstract

Compuestos derivados de heteroarilo-(benceno/heteroarilo) fusionados con actividad antagonista de glucagon; Compounds derived heteroaryl- (benzene / heteroaryl) fused glucagon antagonist activity; composición farmacéutica; pharmaceutical composition; profármaco; I prodrug; y su uso para suprimir la producción de azúcar y para la terapia o el tratamiento de la diabetes. and its use to suppress the production of sugar and for therapy or treatment of diabetes.
CL2009001796A 2008-03-05 2009-09-02 Compounds derived heteroaryl- (benzene / heteroaryl) fused glucagon antagonist activity; pharmaceutical composition; and their use for suppressing sugar production and for therapy or treatment of diabetes. CL2009001796A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2009025511 2009-02-06
PCT/JP2009/054095 WO2009110520A1 (en) 2008-03-05 2009-03-04 Heterocyclic compound

Publications (1)

Publication Number Publication Date
CL2009001796A1 true CL2009001796A1 (en) 2011-09-16

Family

ID=42561095

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009001796A CL2009001796A1 (en) 2008-03-05 2009-09-02 Compounds derived heteroaryl- (benzene / heteroaryl) fused glucagon antagonist activity; pharmaceutical composition; and their use for suppressing sugar production and for therapy or treatment of diabetes.

Country Status (5)

Country Link
AR (1) AR073486A1 (en)
CL (1) CL2009001796A1 (en)
PE (1) PE20100443A1 (en)
TW (1) TWI475018B (en)
UY (1) UY32088A (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881746B2 (en) * 2001-12-03 2005-04-19 Novo Nordick A/S Glucagon antagonists/inverse agonists
US6762318B2 (en) * 2001-12-03 2004-07-13 Novo Nordisk A/S Glucagon antagonists
AU2002365622A1 (en) * 2001-12-03 2003-06-17 Novo Nordisk A/S Novel glucagon antagonists
KR20060022649A (en) * 2003-05-01 2006-03-10 브리스톨-마이어스 스큅 컴퍼니 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
JP2006528687A (en) * 2003-05-09 2006-12-21 メルク エンド カムパニー インコーポレーテッドMerck & Company Incoporated Benzimidazoles, compositions containing such compounds and methods of use
BRPI0618349A2 (en) * 2005-11-17 2011-08-23 Lilly Co Eli pharmaceutically acceptable compound or salt thereof, pharmaceutical composition, and use of a compound or salt thereof

Also Published As

Publication number Publication date
TW201029996A (en) 2010-08-16
TWI475018B (en) 2015-03-01
PE20100443A1 (en) 2010-06-25
AR073486A1 (en) 2010-11-10
UY32088A (en) 2010-08-31

Similar Documents

Publication Publication Date Title
CR20120110A (en) Heterocyclic compounds and uses thereof
GT201400009A (en) 4-imidazopiridazin-1-yl-benzamide and 4-imidazotriazin-1-yl-benzamides as inhibitors btk
CR20140405A (en) Apoptosis regulators signal kinase inhibitor
CL2012002489A1 (en) Compounds derived naphtho-imidazole silyl; pharmaceutical composition; and their use to prevent or treat an infection by Hepatitis C virus.
DOP2010000011A (en) Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
UY35030A (en) Glucagon analogs
CR20130560A (en) Bezotiazol compounds and pharmaceutical use
ECSP12011593A (en) Acylated glucagon analogs
CU20120161A7 (en) 5-fluoro-1H-pyrazolopyridine substituted
CL2014002750A1 (en) An isolated antibody or fragment that binds to an inactive state of a HER receptor; pharmaceutical composition comprising the same; use the antibody to treat cancer
CL2007003774A1 (en) derivatives substituted quinazoline compounds, kinase inhibitors; pharmaceutical composition; and use in the treatment of diseases such as cancer, atherosclerosis and arthritis.
CO6251364A2 (en) Utilazdos morpholino pyrimidine derivatives in diseases related to mTOR kinase and / or P13K
DOP2014000043A (en) Pyrimidines and substituted ringed use thereof
MX2014010560A (en) Pharmaceutical compositions comprising metformin and a dpp -4 inhibitor or a sglt-2 inhibitor.
CO6541656A2 (en) 2-amino-5.5- difluoro-5,6-dihydro-4h-oxazines as BACE1 inhibitors and / or BACE 2
UA109878C2 (en) Izohinolinonu derivatives, pharmaceutical composition based on them (options) and the method of treatment (options)
CR20130487A (en) 1,3-oxazines as BACE1 inhibitors and / or BACE2
CL2013001891A1 (en) Fused heterocyclic compounds; pharmaceutical composition and use in the treatment of macular degeneration associated with age.
DOP2011000279A (en) Benzofuranyl derivatives used as inhibitors glucokinase
CL2016000153A1 (en) Pirrolamida substituted derivatives glyoxamide and their use as medicaments for the treatment of hepatitis b
SV2011004019A (en) 2-acetamido-5-aryl-1,2,4-triazolones substituted and use
CL2011000101A1 (en) pyridazine derivatives substituted compounds; hedgehog signaling inhibitors and smo; pharmaceutical composition; and use for the treatment of disorders or syndromes associated with hyperproliferative diseases.
UY31080A1 (en) Pyrazole derivatives substituted heteroaryl hyperproliferative useful for treating disorders and diseases associated with angiogenesis
CL2015001282A1 (en) Bicyclic compounds of urea, thiourea, guanidine and cyanoguanidine; Preparation process; pharmaceutical composition; useful for the treatment of pain and cancer.
CL2007002610A1 (en) bipyridine derivatives substituted compounds; preparation process; pharmaceutical composition; and use in the treatment and / or prophylaxis of diseases such as hypertension, diabetes, myocardial infarction, among others.